Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Impel NeuroPharma
Pharma
Impel gets FDA nod to challenge Bausch for migraine market
Impel won FDA approval for its dihydroergotamine nasal spray on the strength of a phase 3 trial of 360 migraine patients.
Nick Paul Taylor
Sep 7, 2021 10:55am
Impel NeuroPharma migraine effort points to mind-gut connections
May 26, 2021 9:24am
Impel NeuroPharma migraine effort points to mind-gut connections
May 25, 2021 11:04am
Impel plans $75M IPO to bring nasal migraine drug to market
Apr 12, 2021 12:00pm
FDA sets approval decision date for Impel's nasal migraine drug
Jan 25, 2021 8:05am
